PFE vs ISRG
Pfizer · Intuitive Surgical
| PFE Pfizer Healthcare | ISRG Intuitive Surgical Healthcare | |
|---|---|---|
| Market | ||
| Price | $30.52 +1.90% | $432.01 -3.73% |
| Market cap | $174.0B | $149.8B |
| P/E (TTM) | 40.1 | 50.6 |
| Dividend yield | 5.38% | — |
| 52-week range | $23.62 – $30.67 | $328.57 – $603.88 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Pfizer's Vyndaqel Patent Cliff Just Got Pushed To 2031 — The Market Hasn't Noticed Yet (P… Jun 14, 2026 | Intuitive Surgical (ISRG): Non-GAAP EPS Up 25%, GAAP EPS Down 24%, And A $450M Settlement… Nov 1, 2026 |
| Latest earnings | ||
| Reported | — | Oct 20, 2026 |
| Revenue | — | $3.05 billion +22% YoY |
| EPS | — | $0.99 |
| Guidance | — | Guidance issued |
| Revenue growth, last 4 reports | — | +22% |
| Topics | ||
| Main topics | ||
| Company page | Company page · Earnings releases | |
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.